Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04230863 · ClinicalTrials.gov registry record · NA
Neuroplasticity-Based Cognitive Remediation for Chemotherapy-Related Cognitive Impairment
A NA study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT04230863 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 21 participants.
The verdict
NCT04230863, a NA study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The investigators propose to apply neuroplasticity-based computerized cognitive remediation (nCCR) to treat chemotherapy-related cognitive impairment (CRCI).
Interventions
- BEHAVIORAL Neuroplasticity-based Computerized Cognitive Remediation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2020-02-17 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04230863
The ClinicalTrials.gov registry entry for NCT04230863 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neuroplasticity-based Computerized Cognitive Remediation is the first listed.
NCT04230863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04230863 about?
NCT04230863 is a clinical study titled "Neuroplasticity-Based Cognitive Remediation for Chemotherapy-Related Cognitive Impairment". The investigators propose to apply neuroplasticity-based computerized cognitive remediation (nCCR) to treat chemotherapy-related cognitive impairment (CRCI).
What is the current status of trial NCT04230863?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2020-02-17. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT04230863?
The interventions under investigation include: Neuroplasticity-based Computerized Cognitive Remediation (BEHAVIORAL).
Who is sponsoring clinical trial NCT04230863?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.